The pet wellness industry is experiencing a revolution as innovative startups explore GLP-1 medications traditionally used for human weight management to address obesity in cats. Major pet food manufacturers are simultaneously expanding their portfolios with longevity-focused products, capitalizing on pet owners' increasing willingness to invest in comprehensive animal healthcare. This emerging trend reflects broader shifts in veterinary medicine toward preventative care and pharmaceutical solutions for chronic conditions in companion animals.

Summary auto-generated by AI from the original publisher's content. Editorial standards.